Summary
A thyroid carcinoma cell line, BHT-101, has been established in vitro from a metastatic lymph node deposit in a female patient with a non-hormone producing anaplastic, partly thyroglobulin-and thyroxine (T4)-positive papillary thyroid cancer. The cell population is heterogeneous, containing epithelial-like and fibroblast-like cells, and has a doubling time of 24 h. The cell line is polyploid with hypertetraploid predominance and the karyotype showed trisomies, tetrasomies, pentasomies as well as many marker chromosomes. The majority of the cells are negative or weakly positive for thyroglobulin and thyroxine and estrogen and progesterone receptors are present in the cells. BHT-101 cells produce tumours when injected into immunosuppressed CBA/Ca mice. The cells are sensitive to adriamycin, methotrexate and tamoxifen but not to methimazole (Favistan). The epithelial-like clone 1 and the fibroblastlike clone 3, isolated from the parental line, differed in drug sensitivity. This new cell line is suitable for studying the biology of thyroid carcinoma and for parallel in vivo and in vitro studies of drug activity against thyroid cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aouani S, Hovsépain S, Fayet G (1987) cAMP dependent and independent regulation of thyroglobulin synthesis by two clones of the OVNIS 6H thyroid cell line. Mol Cell Endocrinol 52:151–160
Barranco SC (1975) Review of the survival and cell kinetics effects of adriamycin (NSC-123127) on mammalian cells. Cancer Chemother Rep 6:147–152
Carlsson J, Nilsson K, Westermark B, Pontén J, Sundström C, Larsson E, Bergh J, Pahlman S, Busch C, Collins VP (1983) Formation and growth of multicellular spheroids of human origin. Int J Cancer 31:523–533
Clark OH, Gerend PL, Davis M, Goretzki PE, Hoffman PG (1985) Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissues. J Surg Res 38:89–96
Cooper DS (1984) Antithyroid drugs. New Engl J Med 311:1353–1362
Dralle H, Böcker W, Döhler KD, Schröder S, Haindl H, Geerlings H, Schwarzrock R, Pichlmayr R (1985) Growth and function of thirty-four human benign and malignant thyroid xenografts in untreated nude mice. Cancer Res 45:1239–1245
Estour B, Van Herle AJ, Juillard GJF, Totanes TL, Sparkes RS, Giuliano EA, Klandorf H (1989) Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch[B] 57:167–174
Feldman A, Singh A, Diamond EJ, Schwartz AE, Friedman EW, Davies TF (1987) Variability in production and immunoreactivity of in-vitro secreted human thyroglobulin. Clin Endocrinol 27:691–701
Fogh J, Wright WC, Loveless JD (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58:209–214
Gottlieb JA, Hill CS Jr (1974) Chemotherapy of thyroid cancer with adriamycin. An evaluation of experience with 30 patients. New Eng J Med 290:193–197
Gottlieb JA, Hill CS Jr (1975) Adriamycin (NSC-123127) therapy in thyroid carcinoma. Cancer Chemother Rep 6:283–296
Gottlieb JA, Hill CS Jr, Ibanez ML, Clark RL (1972) Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients. Cancer 30:848–853
Grimm D, Holstädter F, Bauer J, Spruss T, Steinbach P, Bernardt G, Menze R (1992) Establishment and characterization of a human papillary thyroid carcinoma cell line with oxyphilic differentiation (ONCO-DG 1). Virchows Archiv [B] 62:97–104
Hsu S-M, Reine L (1984) The use of avidin-biotin-peroxidase complex (ABC). In: DeLellis RA (ed) Diagnostic and research pathology. Masson Publishing Inc, New York, pp 31–42
Jones GW, Simkovic D, Biedler JL, Southam CM (1967) Human anaplastic thyroid carcinoma in tissue culture. Proc Soc Exp Biol Med 126:426–428
Leong SS, Horoszewicz JS, Shimaoka K, Friedmann M, Kawinski E, Song MJ, Ziegel R, Chu TM, Baylin S, Mirand EA (1981) A new cell line for study of human medullary thyroid carcinoma. In: Andreoli M, Monaco F, Robbins J (eds) Advances in thyroid neoplasia. Field Educational Italia, Rome, pp 95–108
Lowry O, Rosebrough NJ, Farr AB, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:165–175
Mark J, Ekedahl C, Dahlenfors R, Westermark B (1987) Cytogenetical observations in five human anaplastic thyroid carcinomas. Hereditas 107:163–174
Marugo M, Torre G, Bernasconi D, Fazzuoli L, Berta S, Giordano G (1989) Thyroid and steroid receptors. J Endocrinol Invest 12:565–570
Miki H, Oshimo K, Inoue H, Morimoto T, Monden Y (1990) Sex hormone receptors in human thyroid tissues. Cancer 66:1759–1762
Nakamura A, Kakudo K, Watanabe K (1987) Establishment of a new human thyroid medullary carcinoma cell line. Morphological studies. Virchows Arch [B] 53:332–335
Nardulli AM, Greene GL, O’Malley BW, Katzenellenbogen BS (1988) Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: Analysis of estrogen’s effect on progesteron receptor synthesis and degradation. Endocrinology 122:935–944
Okabe T, Nomura H, Oshawa N (1982) Establishment and characterization of a human colony-stimulating factor-producing cell line from a squamous cell carcinoma of the thyroid gland. J Natl Cancer Inst 69:1235–1243
Pályi I, Oláh E, Sugár J (1977) Drug sensitivity studies on clonal cell lines isolated from heteroploid tumour cell populations. I. Dose response of clones growing in monolayer cultures. Int J Cancer 19:859–865
Pályi I (1986) Survival responses to new cytostatic hexitols of P388 mouse and K562 human leukemia cells in vitro. Cancer Treat Rep 70:279–284
Pályi I (1989) Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations. Pathol Res Pract 184:11–17
Péter I, Besznyák I, Szántó J, Füzy M, Bodó M, Sugár J (1989) Clear cell thyroid cancer-undifferentiated type —an immunohistochemical and electron microscopical study. Arch Geschwulstforsch 59:121–128
Pfragner R, Höfler H, Behmel A, Ingolic E, Walser V (1990) Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma. Cancer Res 50:4160–4166
Reiner GCA, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA (1984) Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells. Cancer Res 44:2302–2308
Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Vincze B, Pályi I, Daubner D, Kremmer T, Számel I, Bodrogi I, Sugár J, Seprödi J, Mezö I, Teplán I and Eckhardt S (1991) Influence of luteinizing hormone-releasing hormone agonists on human mammary carcinoma cell lines and their xenografts. J Steroid Biochem Molec Biol 39:119–126
Watkins JF (1977) Production of hybrid cells by fusion of human malignant tumour cells and primary mouse embryo cells. Int J Cancer 20:535–542
Yang K-P, Pearson CE, Samaan NA (1988) Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continous culture. Cancer Res 48:2760–2763
Yang K-P, Samaan NA (1988) Lethal efficacy of doxorubicin on human medullary thyroid carcinoma cells in vitro. Anticancer Res 8:245–248
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pályi, I., Péter, I., Daubner, D. et al. Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101). Virchows Archiv B Cell Pathol 63, 263–269 (1993). https://doi.org/10.1007/BF02899271
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02899271